Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.6K Sell
13,445
-16,205
-55% -$31.5K 0.02% 447
2025
Q4
$45.4K Sell
29,650
-8,571
-22% -$14.2K 0.02% 464
2025
Q3
$56.2K Sell
38,221
-1,787
-4% -$2.66K 0.02% 481
2025
Q2
$71.2K Buy
+40,008
New +$59.3K 0.04% 372
2025
Q1
Sell
-2,670
Closed -$4.08K 520
2024
Q4
$4.08K Buy
+2,670
New +$4.34K ﹤0.01% 1356

Other funds holding CGEN

R Squared's CGEN Position: Q1 2026 in Review

R Squared reduced its Compugen (CGEN) stake by 55% in Q1 2026, selling an estimated $31.5K and leaving 13,445 shares worth $28.6K. The position accounts for 0.02% of the portfolio, ranked #447.

R Squared first reported a position in CGEN in Q4 2024 and has held it in 5 quarters since. The position peaked at $71.2K in Q2 2025. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • R Squared held 13,445 shares of Compugen worth $28.6K as of Q1 2026.
  • R Squared sold 16,205 Compugen shares in Q1 2026, an estimated $31.5K.
  • Compugen made up 0.02% of R Squared's portfolio in Q1 2026, its #447 holding.
  • R Squared first reported a position in Compugen in Q4 2024 and has held it in 5 quarters since.
  • R Squared's Compugen position peaked at $71.2K in Q2 2025.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.